What was the market valuation of chiral chromatography-columns in China in 2024?

The market valuation of chiral chromatography-columns in China was $256.36 Million in 2024. Read More

What is the projected market valuation for chiral chromatography-columns in China by 2035?

The projected market valuation for chiral chromatography-columns in China is $470.04 Million by 2035. Read More

What is the expected CAGR for the China chiral chromatography-columns market during the forecast period 2025 - 2035?

The expected CAGR for the China chiral chromatography-columns market during the forecast period 2025 - 2035 is 5.67%. Read More

Which application segment had the highest valuation in 2024 for chiral chromatography-columns?

In 2024, the Pharmaceuticals application segment had the highest valuation at $180.0 Million. Read More

What are the projected valuations for the Biotechnology application segment by 2035?

The projected valuation for the Biotechnology application segment is $130.0 Million by 2035. Read More

Which material type is expected to show the highest growth in the chiral chromatography-columns market?

The Synthetic Polymers material type is expected to show the highest growth, with a projected valuation of $250.04 Million by 2035. Read More

What was the valuation of Analytical Columns in 2024?

The valuation of Analytical Columns in 2024 was $150.0 Million. Read More

Which end-use segment is projected to have the highest valuation by 2035?

The Manufacturing Units end-use segment is projected to have the highest valuation at $182.04 Million by 2035. Read More

Who are the key players in the China chiral chromatography-columns market?

Key players in the market include Chiral Technologies, Agilent Technologies, and Thermo Fisher Scientific, among others. Read More

What is the projected valuation for the Capillary Columns segment by 2035?

The projected valuation for the Capillary Columns segment is $150.04 Million by 2035. Read More

China Chiral Chromatography Columns Market

ID: MRFR/HC/49420-HCR

200 Pages

Satyendra Maurya

Last Updated: March 02, 2026

China Chiral Chromatography Columns Market Research Report By Application (Pharmaceuticals, Biotechnology, Food and Beverage, Environmental Analysis), By Material Type (Amino Acid Derivatives, Cyclodextrins, Cellulose Derivatives, Synthetic Polymers), By Column Type (Preparative Columns, Analytical Columns, Capillary Columns) and By End Use (Research Laboratories, Manufacturing Units, Quality Control Departments) -Forecast to 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Pharmaceuticals
  2. 4.1.2 Biotechnology
  3. 4.1.3 Food and Beverage
  4. 4.1.4 Environmental Analysis
2. 4.2 Healthcare, BY Material Type (USD Million)
  1. 4.2.1 Amino Acid Derivatives
  2. 4.2.2 Cyclodextrins
  3. 4.2.3 Cellulose Derivatives
  4. 4.2.4 Synthetic Polymers
3. 4.3 Healthcare, BY Column Type (USD Million)
  1. 4.3.1 Preparative Columns
  2. 4.3.2 Analytical Columns
  3. 4.3.3 Capillary Columns
4. 4.4 Healthcare, BY End-Use (USD Million)
  1. 4.4.1 Research Laboratories
  2. 4.4.2 Manufacturing Units
  3. 4.4.3 Quality Control Departments
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Chiral Technologies (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Agilent Technologies (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sigma-Aldrich (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Daicel Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Phenomenex (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Restek Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Waters Corporation (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
3. 6.3 CHINA MARKET ANALYSIS BY MATERIAL TYPE
4. 6.4 CHINA MARKET ANALYSIS BY COLUMN TYPE
5. 6.5 CHINA MARKET ANALYSIS BY END-USE
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY COLUMN TYPE, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY COLUMN TYPE, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY END-USE, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY MATERIAL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY COLUMN TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Pharmaceuticals
Biotechnology
Food and Beverage
Environmental Analysis

Healthcare By Material Type (USD Million, 2025-2035)

Amino Acid Derivatives
Cyclodextrins
Cellulose Derivatives
Synthetic Polymers

Healthcare By Column Type (USD Million, 2025-2035)

Preparative Columns
Analytical Columns
Capillary Columns

Healthcare By End-Use (USD Million, 2025-2035)

Research Laboratories
Manufacturing Units
Quality Control Departments

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”